205 related articles for article (PubMed ID: 35128961)
1. Metformin prevents endothelial oxidative stress and microvascular insulin resistance during obesity development in male rats.
Liu J; Aylor KW; Chai W; Barrett EJ; Liu Z
Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E293-E306. PubMed ID: 35128961
[TBL] [Abstract][Full Text] [Related]
2. Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome.
Jahn LA; Hartline L; Liu Z; Barrett EJ
Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E173-E180. PubMed ID: 34957859
[TBL] [Abstract][Full Text] [Related]
3. Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses.
Zhao L; Fu Z; Wu J; Aylor KW; Barrett EJ; Cao W; Liu Z
J Physiol; 2015 Sep; 593(17):4067-79. PubMed ID: 26108677
[TBL] [Abstract][Full Text] [Related]
4. Metformin's Impact on the Microvascular Response to Insulin.
Love KM; Barrett EJ; Horton WB
Endocrinology; 2022 Oct; 163(11):. PubMed ID: 36201598
[TBL] [Abstract][Full Text] [Related]
5. Metformin improves vascular and metabolic insulin action in insulin-resistant muscle.
Bradley EA; Premilovac D; Betik AC; Hu D; Attrill E; Richards SM; Rattigan S; Keske MA
J Endocrinol; 2019 Nov; 243(2):85-96. PubMed ID: 31394501
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.
Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611
[TBL] [Abstract][Full Text] [Related]
7. Muscle Insulin Resistance and the Inflamed Microvasculature: Fire from Within.
Liu J; Liu Z
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699907
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity.
Zhao L; Fu Z; Wu J; Aylor KW; Barrett EJ; Cao W; Liu Z
Clin Sci (Lond); 2015 Dec; 129(12):1025-36. PubMed ID: 26265791
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity.
Liu J; Aylor KW; Liu Z
Diabetes; 2023 Jul; 72(7):918-931. PubMed ID: 37074396
[TBL] [Abstract][Full Text] [Related]
10. Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats.
van Haare J; Kooi ME; van Teeffelen JW; Vink H; Slenter J; Cobelens H; Strijkers GJ; Koehn D; Post MJ; van Bilsen M
Cardiovasc Diabetol; 2017 Apr; 16(1):47. PubMed ID: 28399917
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 recruits muscle microvasculature and improves insulin's metabolic action in the presence of insulin resistance.
Chai W; Zhang X; Barrett EJ; Liu Z
Diabetes; 2014 Aug; 63(8):2788-99. PubMed ID: 24658303
[TBL] [Abstract][Full Text] [Related]
12. Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment.
Wang N; Chai W; Zhao L; Tao L; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E538-45. PubMed ID: 23299501
[TBL] [Abstract][Full Text] [Related]
13. Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.
Chai W; Liu J; Jahn LA; Fowler DE; Barrett EJ; Liu Z
Diabetes Care; 2011 Jul; 34(7):1634-8. PubMed ID: 21617098
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
15. Muscle insulin resistance resulting from impaired microvascular insulin sensitivity in Sprague Dawley rats.
Premilovac D; Bradley EA; Ng HL; Richards SM; Rattigan S; Keske MA
Cardiovasc Res; 2013 Apr; 98(1):28-36. PubMed ID: 23345263
[TBL] [Abstract][Full Text] [Related]
16. Insulin-induced vasoconstriction is prevalent in muscle microvasculature of otherwise healthy persons with type 1 diabetes.
Jahn LA; Hartline LM; Kleiner AJ; Horton WB; Hasan F; Wai Kit Tan A; Liu Z; Barrett EJ
Am J Physiol Endocrinol Metab; 2023 May; 324(5):E402-E408. PubMed ID: 36920998
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting myeloperoxidase prevents onset and reverses established high-fat diet-induced microvascular insulin resistance.
Chai W; Aylor K; Liu Z; Gan LM; Michaëlsson E; Barrett E
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1063-E1069. PubMed ID: 31593502
[TBL] [Abstract][Full Text] [Related]
18. Effects of tempol on endothelial and vascular dysfunctions and insulin resistance induced by a high-fat high-sucrose diet in the rat.
Bourgoin F; Bachelard H; Badeau M; Larivière R; Nadeau A; Pitre M
Can J Physiol Pharmacol; 2013 Jul; 91(7):547-61. PubMed ID: 23826653
[TBL] [Abstract][Full Text] [Related]
19. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
[TBL] [Abstract][Full Text] [Related]
20. Lack of skeletal muscle liver kinase B1 alters gene expression, mitochondrial content, inflammation and oxidative stress without affecting high-fat diet-induced obesity or insulin resistance.
Chen T; Hill JT; Moore TM; Cheung ECK; Olsen ZE; Piorczynski TB; Marriott TD; Tessem JS; Walton CM; Bikman BT; Hansen JM; Thomson DM
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165805. PubMed ID: 32339642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
